Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-12-17$3.67/sh−48,244$177,200→ 1,470,587 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.